Zus Health has raised $33 million in Series B funding to expand its AI-native healthcare data platform, targeting one of the biggest problems holding back digital healthcare: patient information remains scattered across hospitals, electronic health record systems, pharmacies, laboratories and other providers. Announced on November 10, 2026, the round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures and Alumni Ventures, alongside existing investors Andreessen Horowitz, F-Prime, Maverick Ventures and JAZZ Venture Partners. Founded in 2021 by Jonathan Bush, the former co-founder and CEO of athenahealth, Zus is building a connected patient-record infrastructure that brings information from different sources into a continuously updated view. The company says its total capital raised has now exceeded $100 million. Its larger ambition is to make healthcare data easier to access, understand and use, providing the foundation on which AI-powered clinical applications can operate.

Why Fragmented Patient Records Are a Major Problem for Healthcare
Healthcare has spent decades digitising medical records, but digitisation has not automatically made information easy to share. A patient’s history may be spread across multiple hospitals, specialists, laboratories, pharmacies and insurance-related systems. Each organisation can hold only part of the overall picture, forcing clinicians and administrative teams to search across different sources before they can understand what has happened. Patients may also have to repeat their medical history or rely on memory to explain previous treatments. This fragmentation creates extra work and can make it harder for care teams to access relevant information at the right moment. It also limits the usefulness of AI applications: a system cannot produce a dependable summary of a patient’s history if important information remains disconnected or outdated. Zus is addressing this underlying infrastructure problem by connecting healthcare data before attempting to automate more complex clinical and operational workflows.
Zus Aggregated Profile Creates a More Complete Patient Record
At the centre of the Zus platform is the Zus Aggregated Profile, or ZAP. It is designed to bring information from different healthcare sources into one longitudinal patient record, giving authorised users and applications a broader view of a person’s healthcare history over time. The platform combines data from electronic health records, pharmacy systems, laboratory sources and other clinical networks, then works to organise and enrich that information. Instead of requiring every healthcare organisation or digital health company to build its own aggregation infrastructure, Zus provides a shared foundation that can be accessed through integrations, APIs and embedded applications. This is an important distinction: Zus is not simply offering another electronic health record system. Its focus is on connecting information that may already exist across multiple systems and making it more useful within the applications and workflows where healthcare decisions take place.
A Nationwide Healthcare Data Network Powers the Platform
A connected patient record is only useful if it can receive information from a broad and reliable set of sources. Zus has therefore built a nationwide healthcare data network that connects to EHR networks, pharmacy data, care-event notifications, laboratories and other clinical information systems. This network is designed to continuously enrich and refresh patient records without requiring every customer to establish and maintain each connection independently. The company describes its platform as FHIR-native and API-first, allowing developers and healthcare organisations to integrate connected patient information into their existing software and workflows. That connectivity is strategically important because healthcare data is not created in one place or controlled by one organisation. Zus wants to provide a common data layer that can serve different healthcare applications, from provider organisations and value-based care companies to digital health businesses, diagnostics and precision medicine innovators.

How Zus Uses AI to Turn Medical Records Into Actionable Information
Collecting medical information is only the first step. Healthcare teams also need to understand it quickly and identify the details relevant to a particular task. Zus is developing AI-powered clinical intelligence to transform fragmented records into structured information and useful summaries. One example is its Generated Patient Summaries, which are designed to help care teams review a patient’s history without manually searching through every available document. The company also reports evidence citations across its clinical platform, connecting generated information to supporting records so users can inspect where key details came from. This matters in healthcare because a summary should not be treated as an unsupported answer from a general-purpose chatbot. Clinicians need access to the underlying information and must retain responsibility for clinical decisions. Zus’s approach is to combine AI assistance with connected source records, helping applications surface relevant information while keeping the supporting evidence accessible.
From Patient Data to AI-Powered Clinical Workflows
Zus is moving beyond data aggregation towards workflows that use connected patient information to support everyday healthcare operations. Its platform supports areas such as pre-visit preparation, transitions of care, risk adjustment, quality-gap closure and population health management. These activities often require teams to review information from different providers, identify missing records and determine what needs to happen next. With a more complete patient record, AI-powered applications can help organise relevant information and reduce repetitive administrative work. Zus is also targeting specialty-care use cases, including oncology, where treatment histories, genetic testing and clinical-trial eligibility information can be spread across multiple organisations. The platform is intended to let healthcare companies build specialised applications on top of shared infrastructure instead of recreating data connections for every new product. This positions Zus as a technology layer that can support a wider ecosystem of healthcare software rather than a single-purpose clinical application.
110 Million Network Transactions Show the Scale of Zus’s Data Infrastructure
Zus says its nationwide network supported more than 110 million network transactions in August 2026, while its AI-native clinical platform generated 39 million evidence citations year-to-date across its solutions. These are company-reported figures, but they provide an indication of the activity taking place across its data network and clinical applications. The company also announced its candidacy to become a Qualified Health Information Network under the Trusted Exchange Framework and Common Agreement, known as TEFCA, in August 2026. That is a candidacy announcement, not confirmation that Zus has already been designated as a QHIN. Zus also reports that it holds HITRUST certification, reflecting investment in its security and information-protection framework. These milestones matter because healthcare data infrastructure must address trust, connectivity and security alongside technical performance. The long-term opportunity depends on whether Zus can maintain reliable data flows and expand adoption across an increasingly broad network of healthcare organisations.
What the M Series B Means for the Future of Healthcare AI
Zus plans to use its $33 million Series B to advance its intelligent patient-record platform, expand its national healthcare data network and build more AI-powered clinical workflows. The investment reflects a broader shift in healthcare technology: as hospitals, digital health companies and providers explore AI agents and copilots, the quality and availability of underlying patient data become increasingly important. A model may be capable of summarising records or assisting with administrative tasks, but it cannot provide a complete picture if relevant information is missing, disconnected or stale. Zus is betting that the infrastructure connecting patient records will become as important as the applications built on top of it. The company still faces significant challenges, including data quality, integration complexity, privacy requirements, customer adoption and competition from established health-data networks and software providers. Its next test will be converting network scale into measurable value for healthcare organisations. The Series B gives Zus more capital to pursue that goal: building the connected data foundation that the next generation of healthcare AI applications will need.
Sources
- Zus Health – Official $33M Series B funding announcement, November 10, 2026
- Zus Health – Official platform, patient data network and workflow information
- Fierce Healthcare – Zus Health secures $33M to build infrastructure for AI-powered clinical workflows
- Goodwin – Details of Zus Health’s $33M Series B financing